Permanent Introduction of Premium for New Drug Development Is an Option: Executive Director Miura of JPA

October 3, 2011
In a recent interview of Jiho, Inc., Hirotsugu Miura, executive director of the Japan Pharmaceutical Association and representative of healthcare providers at the Central Social Insurance Medical Council (CSIMC; Chuikyo ), expressed his opinion on the “premium for the development...read more